v3.26.1
Condensed Consolidated Balance Sheets - Unaudited - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 74,868 $ 108,537
Marketable securities 106,696 161,480
Interest receivable 956 1,127
Prepaid assets 2,827 2,808
Prepaid clinical 3,649 3,923
Other current assets 772 2,804
Total current assets 189,768 280,679
Fixed assets, net 56,037 51,231
Right of use assets, net 3,211 3,664
Total assets 249,016 335,574
Current liabilities    
Accounts payable 1,610 940
Lease liabilities 1,129 1,071
Accrued expenses and other 19,971 28,731
Total current liabilities 22,710 30,742
Income tax payable, net of current portion 1,074 1,074
Lease liabilities, net of current portion 2,394 2,965
Total liabilities 26,178 34,781
Commitments and contingencies
Redeemable noncontrolling interest 1,106,370 1,311,990
Stockholders' deficit    
Additional paid-in capital 434,765 258,552
Accumulated other comprehensive (loss) gain (34) 56
Accumulated deficit (1,318,294) (1,269,835)
Total stockholders' deficit (883,532) (1,011,197)
Total liabilities and shareholders' deficit 249,016 335,574
Common Class A [Member]    
Stockholders' deficit    
Common stock value 21 14
Common Class B [Member]    
Stockholders' deficit    
Common stock value $ 10 $ 16